Home
Contact
Squamous cell carcinoma
Home
Squamous cell carcinoma
Filter by
Categories
Tags
Authors
Show all
All
Editorials
New Trials
Ongoing Trials
Trial Results
All
Anal cancer
Antioxidants
Blood cancers
Breast cancer
Caregiving
Chemotherapy
Chronic lymphocytic leukemia
Communication
COVID-19
De-escalation
Esophagus cancer
GI cancer
Green tea
Head and neck cancer
HER2+ breast cancer
Hormone therapy
Immune system therapy
Immunotherapy
In memory
Kidney cancer
Language
Late Effects
Leukemia
Lung cancer
Lymphoma
Mammography
Mantle cell lymphoma
Melanoma
Minimal residual disease
MRI
Multiple myeloma
Myeloma
Neuropathy
Older adults
Pancreatic cancer
Pancreatic cysts
Personalized medicine
Personalized screening
Personalized treatment
Precision medicine
Prevention
Prostate cancer
Renal cell carcinoma
Screening
Side effects
Squamous cell carcinoma
Surveillance
Survivorship
Targeted therapy
Throat cancer
Triple-negative breast cancer
Tumor test
All
Akshay Hanikhindi
Diane Dragaud
ecogacrinnews2
Katie Heller
wpengine
June 8, 2020
June 8, 2020
Categories
New Trials
Now Enrolling: The DECREASE trial seeks to decrease treatment side effects – and improve quality of life – for people with early-stage anal cancer
This study is evaluating whether lower doses of chemoradiation will be able to effectively treat early-stage anal squamous cell carcinoma while also decreasing side effects.
